查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600641

伴同性動物藥品市場：依產品類型、適應症、動物類型、通路 - 2025-2030 年全球預測

Companion Animal Pharmaceuticals Market by Product (Analgesics, Anti-infectives, Anti-inflammatory), Indication (Behavioral Disorders, Dermatologic Diseases, Infectious Diseases), Animal Type, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年伴同性動物藥品市場價值為143.9億美元，預計到2024年將達到152.8億美元，複合年成長率為6.67%，預計到2030年將達到226.2億美元。

伴同性動物藥品市場包括專為寵物（包括狗、貓和其他家畜）設計的藥品和藥物，包括疼痛管理、疫苗接種、感染疾病、疫苗、抗寄生蟲藥物和皮膚病學等醫療需求。 。在將寵物視為家庭成員以及對動物健康和保健的興趣的人性化趨勢的推動下，隨著全球寵物擁有的增加，這一領域變得越來越重要。獸醫學的進步、寵物保健意識的提高以及寵物相關服務支出能力的提高推動了需求。准入市場延伸至獸醫院、家庭藥局、網路銷售平台。關鍵的成長要素包括寵物擁有量的增加、獸醫基礎設施的蓬勃發展、藥物配方的技術進步以及慢性寵物疾病的快速增加。機會包括注射劑的口服替代品的開發、針對個別動物的個人化醫療，以及寵物擁有量不斷增加的新興市場的成長機會。然而，他們面臨藥品價格上漲、藥品核准嚴格的監管要求以及阻礙採用的藥物潛在副作用等障礙。經濟放緩將影響寵物醫療保健支出，並對市場擴張構成進一步挑戰。創新可以圍繞著開發環保、安全和具有成本效益的藥物，以及利用生物技術開發新型療法。製藥公司和獸醫醫院之間的合作研究可能會在治療效果和安全性方面帶來突破。補充藥品的治療性營養和保健產品的趨勢預計也將推動市場開拓。該市場具有競爭性和動態性，其特點是技術快速進步和飼主偏好不斷變化，需要即時市場分析和適應性策略來應對不斷變化的人口統計和不斷變化的消費者需求。成功地將技術創新與消費者需求結合的公司可望佔領重要的市場佔有率。

主要市場統計
基準年[2023] 143.9億美元
預測年份 [2024] 152.8億美元
預測年份 [2030] 226.2億美元
複合年成長率（%） 6.67%

市場動態：快速發展的伴同性動物藥品市場的關鍵市場洞察

供需的動態交互作用正在改變伴同性動物藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 通用和慢性感染疾病的盛行率不斷增加
    • 伴同性動物數量和衛生意識的增加
    • 提高大眾對動物保健的認知和支出
  • 市場限制因素
    • 與伴同性動物健康 API 相關的一些風險因素
  • 市場機會
    • 伴同性動物新藥和疫苗的開發
    • 新興經濟體市場參與者與策略聯盟的出現
  • 市場挑戰
    • 嚴格藥品核准相關規定

波特五力：駕馭伴同性動物藥品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解伴同性動物藥品市場的外部影響

外部宏觀環境因素在塑造伴同性動物藥品市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解伴同性動物藥物市場的競爭狀況

對伴同性動物藥品市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣伴同性動物藥品市場供應商的績效評估

FPNV 定位矩陣是評估伴同性動物藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 通用和慢性感染疾病的盛行率增加
      • 寵物數量的增加和衛生意識的增加
      • 提高大眾對動物保健的認知和支出
    • 抑制因素
      • 與寵物動物用藥品相關的一些風險因素
    • 機會
      • 寵物新藥和疫苗的開發
      • 新興經濟體市場參與者的出現與策略合作
    • 任務
      • 藥品核准嚴格規定
  • 市場區隔分析
    • 產品：多種止痛藥，用於治療寵物的一般疼痛和慢性疼痛
    • 適應症：日益關注開發寵物抗菌素抗藥性和感染疾病的先進藥物
    • 動物類型：越來越多的人引入狗作為寵物，其治療費用也在增加。
    • 分銷管道：提高透過線上管道獲取伴同性動物藥品的可近性和便利性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章伴同性動物藥品市場：依產品

  • 止痛藥
  • 抗感染
  • 發炎（藥
  • 醫藥添加劑和飼料添加劑
  • 寄生劑
  • 疫苗

第7章伴同性動物藥品市場適應症

  • 行為障礙
  • 皮膚病
  • 感染疾病
  • 整形外科疾病
  • 疼痛

第8章依動物類型分類的伴同性動物藥品市場

  • 貓
  • 狗
  • 馬

第9章伴同性動物藥品市場：依通路分類

  • 網路藥房
  • 零售藥房
  • 獸醫診所
  • 動物醫院

第10章美洲伴同性動物藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區伴同性動物藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲伴同性動物藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 勃林格殷格翰在印度推出 NexGard SPECTRA，這是一種為狗提供全面寄生蟲保護的新型咀嚼解決方案
    • Zoetis 獲得 FDA核准突破性犬骨關節炎和過敏治療
    • Axton Biosciences 將重點轉向寵物健康並利用尖端技術開發新治療方法
    • Zoetis 透過收購 Jurox 擴大全球影響力，加強寵物和牲畜護理動物醫藥產品組合

公司名單

  • Phibro Animal Health Corporation
  • Hipra Laboratories, SA
  • Vetneeds Group
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Tianjin Ringpu Biotechnology Co., Ltd.
  • Stanex Drugs and Chemicals Pvt Ltd.
  • Indian Immunologicals Ltd.
  • Alivira Animal Health Limited
  • Kyoritsu Seiyaku Corporation
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • SkyEc Pharmaceuticals Private Limited
  • Endovac Animal Health, LLC
  • Lutim Pharma Pvt. Ltd.
  • Virbac SA
  • Ceva Sante Animale
  • Meiji Group
  • Boehringer Ingelheim International GmbH
  • Century Pharmaceuticals Ltd.
  • Zydus Animal Health
  • Vetbiolix
  • Merck & Co. Inc.
  • Veko Care
  • Ashish Life Science Pvt. Ltd.
  • Chanelle Pharma
  • Zoetis Inc.
  • Hester Biosciences Limited
  • Orion Corporation
  • Eco Animal Health Group PLC
Product Code: MRR-FD3F12D52B58

The Companion Animal Pharmaceuticals Market was valued at USD 14.39 billion in 2023, expected to reach USD 15.28 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 22.62 billion by 2030.

The companion animal pharmaceuticals market encompasses drugs and medications designed specifically for pets, including dogs, cats, and other domesticated animals, addressing medical needs such as pain management, vaccination, anti-infectives, vaccines, parasiticides, and dermatological treatments. This sector is increasingly vital as pet ownership rises globally, driven by humanization trends where pets are viewed as family members, alongside concerns for animal health and wellness. Demand is propelled by advancing veterinary medicine, growing awareness of pet healthcare, and increased spending capability on pet-related services. The accessible market extends across veterinary clinics, home pharmacies, and online sales platforms. Key growth influencers include the increase in pet adoption rates, burgeoning veterinary infrastructure, technological advancements in drug formulations, and proliferation of chronic pet diseases. Opportunities arise from developing oral alternatives to injections, personalized medicine tailored to individual animals, and growth in emerging markets with rising pet adoption rates. However, market growth faces obstacles such as high cost of pharmaceuticals, stringent regulatory requirements for drug approval, and potential side effects of medications that could deter adoption. Economic slowdown impacts spending on pet healthcare, further challenging market expansion. Innovation can pivot around the development of eco-friendly, safe, and cost-effective medications, and leveraging biotechnology for novel therapeutics. Collaborative research between pharmaceuticals and veterinary institutions might offer breakthroughs in treatment efficacy and safety. Trending interest in therapeutic nutrition and wellness products supplementary to pharmaceuticals can also drive market exploration. The market is competitive and dynamic, characterized by rapid technological advancements and shifts in pet owner preferences, necessitating real-time market analysis and adaptive strategies to address demographic changes and evolving consumer needs. Companies successful in marrying innovation with consumer demand are poised to capture significant market share.

KEY MARKET STATISTICS
Base Year [2023] USD 14.39 billion
Estimated Year [2024] USD 15.28 billion
Forecast Year [2030] USD 22.62 billion
CAGR (%) 6.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Pharmaceuticals Market

The Companion Animal Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Zoonotic and Chronic Diseases
    • Rising Number of Companion Animals and Awareness About their Hygiene
    • Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
  • Market Restraints
    • Several Risk Factors Associated with Companion Animal Health APIs
  • Market Opportunities
    • Development of New Drugs and Vaccines for Companion Animal
    • Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
  • Market Challenges
    • Stringent Regulations Associated with the Approval for Drugs

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Pharmaceuticals Market

A detailed market share analysis in the Companion Animal Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Phibro Animal Health Corporation, Hipra Laboratories, S.A., Vetneeds Group, Neogen Corporation, Norbrook Laboratories Ltd., Tianjin Ringpu Biotechnology Co., Ltd., Stanex Drugs and Chemicals Pvt Ltd., Indian Immunologicals Ltd., Alivira Animal Health Limited, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, SkyEc Pharmaceuticals Private Limited, Endovac Animal Health, LLC, Lutim Pharma Pvt. Ltd., Virbac S.A., Ceva Sante Animale, Meiji Group, Boehringer Ingelheim International GmbH, Century Pharmaceuticals Ltd., Zydus Animal Health, Vetbiolix, Merck & Co. Inc., Veko Care, Ashish Life Science Pvt. Ltd., Chanelle Pharma, Zoetis Inc., Hester Biosciences Limited, Orion Corporation, and Eco Animal Health Group PLC.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analgesics, Anti-infectives, Anti-inflammatory, Medicated Feed Additives, Parasiticides, and Vaccines.
  • Based on Indication, market is studied across Behavioral Disorders, Dermatologic Diseases, Infectious Diseases, Orthopedic Diseases, and Pain.
  • Based on Animal Type, market is studied across Cats, Dogs, and Horses.
  • Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Zoonotic and Chronic Diseases
      • 5.1.1.2. Rising Number of Companion Animals and Awareness About their Hygiene
      • 5.1.1.3. Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Several Risk Factors Associated with Companion Animal Health APIs
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of New Drugs and Vaccines for Companion Animal
      • 5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent Regulations Associated with the Approval for Drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Diverse range of analgesics to treat general and chronic pain in companion animals
    • 5.2.2. Indication: Rising focus on developing advanced pharmaceuticals for antimicrobial resistance and infectious diseases in companion animals
    • 5.2.3. Animal Type: Increased adoption of dogs as companion animals and rising expenditure on their treatments
    • 5.2.4. Distribution Channel: Enhanced accessibility and convenience of attaining companion animal pharmaceuticals through online channels
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Companion Animal Pharmaceuticals Market, by Product

  • 6.1. Introduction
  • 6.2. Analgesics
  • 6.3. Anti-infectives
  • 6.4. Anti-inflammatory
  • 6.5. Medicated Feed Additives
  • 6.6. Parasiticides
  • 6.7. Vaccines

7. Companion Animal Pharmaceuticals Market, by Indication

  • 7.1. Introduction
  • 7.2. Behavioral Disorders
  • 7.3. Dermatologic Diseases
  • 7.4. Infectious Diseases
  • 7.5. Orthopedic Diseases
  • 7.6. Pain

8. Companion Animal Pharmaceuticals Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Cats
  • 8.3. Dogs
  • 8.4. Horses

9. Companion Animal Pharmaceuticals Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Online Pharmacies
  • 9.3. Retail Pharmacies
  • 9.4. Veterinary Clinics
  • 9.5. Veterinary Hospitals

10. Americas Companion Animal Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Companion Animal Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Boehringer Ingelheim Introduces NexGard SPECTRA in India, a New Chewable Solution for Comprehensive Dog Parasite Protection
    • 13.3.2. Zoetis Receives FDA Approval for Groundbreaking Canine Osteoarthritis and Allergy Treatments
    • 13.3.3. Akston Biosciences Shifts Focus to Pet Health, Using Cutting-Edge Technology to Develop New Treatments
    • 13.3.4. Zoetis Expands Global Reach with Acquisition of Jurox, Enhancing Veterinary Medication Portfolio for Companion and Livestock Care

Companies Mentioned

  • 1. Phibro Animal Health Corporation
  • 2. Hipra Laboratories, S.A.
  • 3. Vetneeds Group
  • 4. Neogen Corporation
  • 5. Norbrook Laboratories Ltd.
  • 6. Tianjin Ringpu Biotechnology Co., Ltd.
  • 7. Stanex Drugs and Chemicals Pvt Ltd.
  • 8. Indian Immunologicals Ltd.
  • 9. Alivira Animal Health Limited
  • 10. Kyoritsu Seiyaku Corporation
  • 11. Dechra Pharmaceuticals PLC
  • 12. Elanco Animal Health Incorporated
  • 13. SkyEc Pharmaceuticals Private Limited
  • 14. Endovac Animal Health, LLC
  • 15. Lutim Pharma Pvt. Ltd.
  • 16. Virbac S.A.
  • 17. Ceva Sante Animale
  • 18. Meiji Group
  • 19. Boehringer Ingelheim International GmbH
  • 20. Century Pharmaceuticals Ltd.
  • 21. Zydus Animal Health
  • 22. Vetbiolix
  • 23. Merck & Co. Inc.
  • 24. Veko Care
  • 25. Ashish Life Science Pvt. Ltd.
  • 26. Chanelle Pharma
  • 27. Zoetis Inc.
  • 28. Hester Biosciences Limited
  • 29. Orion Corporation
  • 30. Eco Animal Health Group PLC

LIST OF FIGURES

  • FIGURE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPANION ANIMAL PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023